NASDAQ · Shell Companies · USD

Archimedes Tech SPAC Partners III Co. (ARCI) Stock Analysis

Archimedes Tech SPAC Partners III Co. (ARCI) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 20, 2026

ARCI

$10.04

−$0.00 (−0.05%)

Oct 20, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ARCI with… →

ARCI Key Statistics

As of Oct 20, 2026

Trading

Open: $10.05
Previous Close: $10.04
Day's Range: 10.04–10.05
52-Week Range: 9.83–10.20
Volume: 408.00

Valuation

Market Cap: $353.85M

Financials (FY)

Shares Outstanding: 35.26M

Dividend and dates

Avg Volume: 42.20K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Archimedes Tech SPAC Partners III Co. (ARCI) has a market capitalization of $353.85M.

Analysis

Data-derived

Company Overview

Archimedes Tech SPAC Partners III Co. (ARCI) is capitalised at $353.85M on the latest close. The company sits in the Financial Services sector, in the Shell Companies industry.

The most recent close on file for ARCI is $10.04, dated October 20, 2026. That is $0.00 (−0.05%) against the previous close. Over the past 52 weeks the price has ranged from $9.83 to $10.20. The latest close sits 2.09% above that 52-week low.

Valuation Assessment

The stored price history starts on March 16, 2026, and the total return since then is +1.88%.

Growth & Income

The record shows no dividend for ARCI.

So far in 2026 the total return is +1.88%.

Peer Comparison

Archimedes Tech SPAC Partners III Co. (ARCI) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Archimedes Tech SPAC Partners III Co.	ARCI	$353.85M	—
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Archimedes Tech SPAC Partners III Co. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$596.26M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Archimedes Tech SPAC Partners III Co.

Archimedes Tech SPAC Partners III Co. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Claymont, Delaware.

Visit website →